Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 9 of 25
Cryovagotomy Diabetes Trial
NCT04276051
Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women
NCT04531943
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
NCT04426838
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101
Healthy Homes/Healthy Families (HH/HF) Intervention in 2-1-1 Callers
NCT04373434
Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation
NCT04409301
Are Opioids Needed After ACL Reconstruction
NCT04285853
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
NCT04524702
Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia
NCT03818516
iTransition Development
NCT04383223
GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis
NCT04253834
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
NCT04495894
Dapagliflozin at Discharge on Hospital Heart Failure Readmission
NCT04249778
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
NCT04441996
Convalescent Plasma in Pediatric COVID-19
NCT04458363
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
NCT04352205
WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors
NCT04334863
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
NCT04366791
Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
NCT04331366
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
NCT04118010
Out of Pocket Cost Communication in Multiple Sclerosis Patients
NCT04257071
Biomarkers for Event-driven PrEP Adherence
NCT04298697
Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis
NCT04123197
Life Care Specialists (LCS) With a Focus on Patient Pain Management and Prevention of Substance Misuse
NCT04154384
Implementation of Rapid HIV Self-Testing Among MSM Project
NCT04219878
SPIRIT for Persons With Dementia and Complex Multimorbidity
NCT04108000
Dry Needling for Cervicogenic Headache
NCT04305223
Comparison of Dietary Sugar Reduction Methods
NCT04186793
Solid Organ Transplant SHINGRIX
NCT03993717
HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)
NCT03763942
AflacLL1901 (CHOA-AML)
NCT04326439
Hemodynamics Measurement in Radiofrequency Catheter Ablation
NCT04227119
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer
NCT04191421
Effects of Sensory Flicker and Electrical Flicker Stimulation
NCT04188834
Mindfulness IN-home for Diabetes and Sleep Health
NCT04160078
Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System
NCT04276194
Low-dose Y90 Treatment Planning for HCC
NCT04172714
Cortical Contributions to Motor Sequence Learning
NCT04138953
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
NCT04157738
Systems Biology of Zoster Vaccine
NCT04047979
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362
Neuroendocrine Risk for PTSD in Women
NCT03973229
Safety and Effectiveness of the Peregrine Drivable ENT Scope for Endoscopy of the Paranasal Sinuses
NCT04096482
Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery
NCT04221594
Soccer Intervention in Prostate Cancer Survivors
NCT04144127
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
NCT04080531
Dialectical Behavior Therapy for Pregnant Women
NCT03938350
The Use of 3D Printing in Orbital Fractures
NCT03673865
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
NCT04039217
Montelukast Therapy on Alzheimer's Disease
NCT03991988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Emory University pipeline card: 1,208 registered trials from official public datasets.Report a data error.